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Abstract
Background: Randomised clinical trials are the ‘gold standard’ for evaluating the effectiveness of healthcare
interventions. However, successful recruitment of participants remains a key challenge for many trialists. In this
paper, we present a conceptual framework for creating a digital, population-based database for the recruitment of
asthma patients into future asthma trials in the UK. Having set up the database, the goal is to then make it
available to support investigators planning asthma clinical trials.
Methods: The UK Database of Asthma Research Volunteers will comprise a web-based front-end that interactively
allows participant registration, and a back-end that houses the database containing participants’ key relevant data.
The database will be hosted and maintained at a secure server at the Asthma UK Centre for Applied Research
based at The University of Edinburgh. Using a range of invitation strategies, key demographic and clinical data will
be collected from those pre-consenting to consider participation in clinical trials. These data will, with consent, in
due course, be linkable to other healthcare, social, economic, and genetic datasets. To use the database, asthma
investigators will send their eligibility criteria for participant recruitment; eligible participants will then be informed
about the new trial and asked if they wish to participate. A steering committee will oversee the running of the
database, including approval of usage access. Novel communication strategies will be utilised to engage
participants who are recruited into the database in order to avoid attrition as a result of waiting time to
participation in a suitable trial, and to minimise the risk of their being approached when already enrolled in a trial.
Results: The value of this database will be whether it proves useful and usable to researchers in facilitating
recruitment into clinical trials on asthma and whether patient privacy and data security are protected in meeting
this aim.
Conclusions: Successful recruitment is fundamental to the success of a clinical trial. The UK Database of Asthma
Research Volunteers, the first of its kind in the context of asthma, presents a novel approach to overcoming
recruitment barriers and will facilitate the catalysing of important clinical trials on asthma in the UK.
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Background
Randomised clinical trials are the ‘gold standard’ for
evaluating the effectiveness of interventions in reaching
medical and policy decisions [1, 2]. Often clinical trials
run into difficulties, with slow or inadequate recruitment
of participants being a particularly common reason for
trials failing to deliver [3–9]. In the UK, only 55 % of tri-
als funded by the National Institute of Health Research
Health Technology Assessment (NIHR HTA) and the
Medical Research Council achieved their original re-
cruitment target on time, whilst 45 % received an exten-
sion of time to recruit [4, 6]. This trend shows no sign
of improvement over time [4].
Recruitment is an important measure by which the
overall success of a trial may be gauged [6, 9]. Poor re-
cruitment gives rise to underpowered studies or leads to
extension of overall time lines for the completion of tri-
als, often incurring additional costs and compromising
the relevance of findings [7, 9]. Strategies to improve re-
cruitment into trials include telephone reminders, opt-
out procedures, and open designs, but their impact on
enhanced recruitment appears to be marginal [5, 8, 9].
There is growing interest in the potential of routine
healthcare data, particularly electronic health records
(EHRs), to enhance the efficiency of conducting clinical
trials [10–14]. The feasibility and success of utilising
stand-alone or linked routine datasets in conducting
trials has been evaluated, and clearly evidence points in
the direction of improved recruitment and conduct of
clinical trials [10–14]. With respect to participant recruit-
ment, EHRs have been used for point-of-care enrolment
and randomisation, with clinicians employing opportunistic
patient recruitment strategies during consultation or using
information systems such as flagging or care-scheduling
pop-ups [13, 15]. Whilst most clinicians are, in principle,
generally in favour of becoming involved in recruiting pa-
tients into trials, actual involvement can be complex and
time-consuming for often already over-stretched frontline
clinical staff [4, 6, 8, 16, 17]. Time constraints, impact on
clinician-patient relationship, and added workload to
already busy schedules constitute other considerations that
may hinder clinicians’ involvement in patient recruitment
(Fig. 1) [4, 6, 8, 16, 17]. This results in patients seldom
being invited to participate, even though research sug-
gests that many patients are willing to be recruited into
trials [8, 16]. There is, therefore, a need to find novel ap-
proaches that do not add to the workload of clinician
gatekeepers by approaching patients directly with a view
to offering them the opportunity to participate in clin-
ical trials [16].
In this paper, we present a conceptual framework for
creating a database for the recruitment of volunteers who
are willing and eligible to participate in future asthma clin-
ical trials in the UK. The UK ranks among the countries
Participant recruitment via GPs Recruiting for the UK Database of Asthma Research Volunteers in  
which request for recruitment is directly to the participant
Fig. 1 A schematic contrast of general practitioner (GP) and open recruitment for potential clinical trials showing the underlying challenges
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with the highest prevalence, healthcare utilisation and
mortality from asthma [18, 19]; therefore, asthma serves
as an appropriate exemplar disease condition for creating
this database. Successful development of this initiative in
this common clinical area could pave the way for similar
developments in other chronic disease areas. The overall
goal is to establish a digital population-based database of
asthma patients across all age groups who pre-consent to
be contacted to take part in future asthma clinical trials
and give their consent for their EHRs to, in due course, be
scrutinised and cross-linked to other health, genetic,
social, and economic datasets in order to determine eligi-
bility to participate and tailor invites accordingly. Having
set up the database, the goal is to then make it available to
investigators planning a range of asthma clinical trials from
across the UK. We also present selected analogous existing
clinical research recruitment databases (Additional file 1)
that serve as ‘learning experiments’ for highlighting the
feasibility, features, benefits, and challenges of the proposed
database [20–23]. Finally, we discuss the likely added values
of the database to research, practice, and policy as we aim
to increase the efficiency with which clinical trials on
asthma are undertaken in the UK.
Methods
Database design and set-up
The design and set-up of the database will closely follow
the approaches used to establish the generalist National
Health Service Scotland (NHS Scotland) Scottish Health
Research Register (SHARE) which targets all people in
Scotland for recruitment [16]. There are, however, some
modifications with regards to the management of the re-
cruitment process for trials being undertaken within the
database and, more fundamentally, the UK-wide focus of
our initiative. After careful consideration of the structural
set-up and applicable recruitment management processes
of similar existing databases (Additional file 1), we decided
to follow the Duke Clinical Research Unit (DCRU) model
[22], in which the database administrators are involved in
all stages of the recruitment process for each study under-
taken within the database. Whereas SHARE allows inves-
tigators using the database direct contact with potential
participants, the DCRU team directly undertakes the re-
cruitment process on behalf of each study and manages
the process until the end of the study. This, we believe,
ensures the opportunity for careful management of the re-
cruitment process, minimises the risk of exploitation of
participants’ privacy from investigators, and consequently
will provide greater confidence from participants and en-
sure their continuous involvement in the database.
The database will comprise front-end and back-end
components. The front-end refers to the interface where
users interact with a computer or handheld electronic de-
vice through which they are able to browse or navigate
using tools like icons and dropdown menus. On the other
hand, the back-end is the underlying database structure
and the technology that houses databases, web applica-
tions, and helps to power the components that enable the
user-face (front-end) of the website to perform optimally.
After setting up the database, the fundamental strategies
to populating and utilising the database will involve seven
integrated stages as outlined and explained below and
illustrated in Fig. 2:
1. Invitation sent to potential asthma participants to
join the database using different invitation
approaches: all those invited are asked to complete a
short questionnaire asking for some demographic
data, such as age, sex, and place of residence
2. Those who agree and consent to participate will
then register in the database
3. Information on volunteers’ asthma status and
current use of asthma medications will be requested
4. Asthma research investigators send in their
eligibility criteria for selection of participants from
the database to take part in planned clinical trials
5. The database is queried against the eligibility criteria
of each project to identify potential participants in
respective clinical trials
6. The list of eligible potential participants (containing
basic demographics but without any identifiable
participant information) is sent back to researchers
through a secure interface that will be dedicated to
the database. If researchers are satisfied with the list,
those who are eligible will then be invited to take
part in the study
7. During the life of a specific trial and continuously
for the database, we will employ novel
communication strategies to continue to engage
participants already recruited into the database
Investigators will have the opportunity to undertake
emerging clinical design strategies using the database if
needed. For example, using the stepped-wedge design, gen-
eral practitioner (GP) practices can serve as useful clusters
for randomisation. Other possible designs that can be im-
plemented include n-of-1 trials (which can be enhanced
through wearable data that can be collected and directly
populated in the platform’s secure database for further pro-
cessing) and adaptive clinical trials, which can provide an
opportunity to implement relevant adaptations to the trial
and statistical procedures without major contamination of
the planned trial process given that the population re-
cruited into the platform should remain stable over time. In
addition, to advancing multi- and cross-disciplinary re-
search, the database will provide an infrastructure to link
data from the database to other health, social, economic,
and genetic datasets on an ongoing basis.
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Diagrammatically, the set-up, recruitment approaches,
and milestones of the database are shown in Fig. 3. The
population in the database will include people of all ages.
We will devote the first year to building the relevant
structures for full launch of the database, including:
piloting a beta version of the database, securing further
funding; establishing ethical and governance oversight
committees; setting up remote and physical study sites;
creating integrated recruitment approaches; establishing
collaborations across the UK; and identifying candidate
asthma projects that can first use the database. In order
to maintain a continuous retention of participants within
the database, our aim is to start recruitment of partici-
pants into small-scale clinical trials as soon as possible
after sufficient (i.e. n >1000) participant enrolment into
the database. Participants are likely to withdraw their
participation from the database if it takes too long to ini-
tiate their participation in a study from when they en-
rolled in the database. Therefore, during the first year of
preparatory work for setting up the database, we will
concurrently identify potential asthma clinical trials
across the UK that are at the planning stages and liaise
with the investigators on utilising the database for their
projects once launched. In this way, recruited registrants
who are eligible for participation in a particular trial will
have the opportunity to be enrolled into a study within a
short time from registration. From the second year, we
aim to achieve recruitment of at least 75,000 registrants
per year to a final 300,000 during the first 5 years.
Recruitment approaches
Recruitment strategies of potential participants will be
carried out via:
1. Asthma UK – we are working in close
partnership with Asthma UK, the national patient
charity and support organisation, to recruit
participants through their existing databases.
Asthma UK will play a major role in supporting
our recruitment campaign
2. Members of our Patient and Public Involvement
(PPI) Group will help in canvassing participants for
Invite 
Participant 
• Invitation sent to potential asthma participants to join the platform using 
different invitation approaches
Consent & 
Register
• Those agreeing and consent to participate will then register in the platform
Eligibility 
Criteria 
• Investigators send in their eligibility criteria for selection of participants 
from the platform (for clinical trials)
Query for 
Eligible  
• The database is queried against the eligibility criteria of each project to 
identify potential participants in a respective clinical trial
Anonymise 
Data
• Anonymised list of eligible potential participants is sent back to investigator 
via secure interface dedicated to the platform. 
• If researchers are satisfied with the list retrieved, those eligible will then be 
contacted to take part in the study
Engage 
Participant
• To employ novel communication strategies that will actively engage 
participants. For e.g. by  providing handy information, alerts, online tools 
and mobile applications that are relevant for self-monitoring and 
management of asthma
Fig. 2 Strategies to populate and use the UK Database of Asthma Research Volunteers
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recruitment through handing out of flyers and word
of mouth
3. A snowball sampling approach will be used to reach
out to participants by asking those already enrolled
in the database to help invite their network of
contacts
4. Approaching people who are already participating in
asthma studies, and people with asthma who are
participating in non-asthma studies
5. Capitalising on the opportunities offered by both the
electronic and print media, including strategic
advertisements on local television and radio stations,
the Internet, and local newspapers in reaching out
to potential participants
6. SHARE – we will search the SHARE database in order
to identify potentially eligible asthma patients who are
already taking part in SHARE and invite them to
participate. We will seek to develop a reciprocal
arrangement whereby database volunteers would be
asked to participate in SHARE and vice versa
7. GP practices – we will liaise with GP practices to
invite participants through personalised direct mail
endorsed by the patients’ GP. In addition, we will
enclose invitation letters with outpatient
appointment letters to eligible participants
Those who consent to enrol into the database will
complete an enrolment form that asks for some basic
demographic information and information that assesses
their asthma status (Additional file 2).
Project time lines and milestones
The project time lines are shown in Fig. 3 to show the
anticipated milestones within the first 5 years.
Cross-data linkages and data management
Given the possibilities that are now available in the UK to
undertake deterministic cross-data linkages using the
unique identifiers, Community Health Index (CHI) number
in Scotland and NHS numbers in England, Wales and
Northern Ireland, having set up the database, we aim, in
due course, to link data from the database on an ongoing
basis to other routinely-collected health, genetic, economic,
and social datasets for participants who consent to allow us
to undertake data linkages of their data. These data linkages
will provide the opportunity for recruiting participants into
trials that will be investigating both clinical and non-clinical
asthma outcomes; they will also enhance the possibility of
undertaking long-term follow-up of clinical trials to be
undertaken using the database.
The back-end of the database will collate and populate
the relevant data obtained from enrolled participants. The
Structured Query Language (SQL) routines (with enabled
features to easily convert to other database formats) will be
used as the default programme to manage participants’
data. The collected data will automatically be encrypted
and routed to the project database systems and hosted via a
secure portal at The University of Edinburgh. These data
will be stored on secure encrypted servers with password-
secured access restricted to designated database administra-
tors. The database management administrators will be re-
sponsible for all issues related to data coding, security,
access and audit. Administrators will ensure compliance
with Data Protection Act Principles [24]. The database ad-
ministrator will work closely with the database investigators
and the steering committee in developing all functions re-
quired for data management. The register will be routinely
monitored for changes in population dynamics. Standard
data quality checks will be performed and reported on an
ongoing basis.
Electronic and 
print media
Recruitment strategies 
feeding into the database
Register of 
potentially 
eligible asthma 
patients
AUK patient 
database
AUKCAR PPI 
group  contacts
Asthma patients
in SHARE
via GP practices
Word of 
mouth
Linked and complete 
data ready for specific 
asthma trial at a 
particular point in 
time. Potentially 
eligible participants 
extracted from the 
register based on 
researchers inclusion 
and exclusion criteria
2 years: 75000 registrants 
recruited
3 years: 150000 
registrants 
recruited
1 year: preparation of all 
the structural set-ups for 
the platform
Use of database by asthma trialists:
- Interested asthma trialists send request to use the register with 
specified inclusion and exclusion criteria for potential participants
- Query is run in the register to identify potential participants
- List of potential participants sent back to researchers
- If linkage of register to other data sources is requested, linkage 
will be undertaken
Data linkages to be 
undertaken on an 
ongoing basis as 
desired by trial 
researchers
Maternity data
Neonatal data
Scottish Health 
Survey data
Birth data
GP data
Prescribing data
5 years: 300000 
registrants recruited
Fig. 3 Diagrammatical description of the UK Database of Asthma Research Volunteers. Platform for Recruitment and Conduct of Clinical Research on Asthma
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Ethics, governance, and data security
NHS Research Ethics Committee approval is not re-
quired for setting up a research volunteer database, but
we will apply for ethics approval when we require fur-
ther patient information, need to search GP records and
undertake data linkages.
A steering committee is being set up, involving leading
project investigators and representatives of Asthma UK,
government and patient and public groups. The commit-
tee’s primary tasks will be to oversee the running of the
database, including approval of access to use the data-
base, review of data-gathering tools/approaches used
within the database, approval of data requests, provision
of guidance on dealing with privacy and security issues
arising from using the database, and provision of general
advice on the day-to-day running of the database as
these arise. The committee will also guide and ensure
that data management procedures meet and align with
the project’s strategic interest in asthma clinical trials.
Collaborators
We are collaborating with Asthma UK and will seek
additional collaborators as and when required.
The role of the patient groups
Within the Asthma UK Centre for Applied Research, a
PPI group is involved in asthma projects to ensure that
the perspectives of patients and families affected with
asthma are clearly integrated. We have, therefore, en-
gaged the PPI group throughout the processes of devel-
oping the database. At each stage of development; for
example, when developing the database prototype, we
sought and integrated the PPI group feedback. We will
continue to work with the PPI group as we progress
with the development of the database.
Project status
Most preliminary background work for establishing the
database has been completed. We have now liaised with in-
vestigators of similar databases (Additional file 1), with the
view of understanding their experiences that we hope will
be integrated in developing the frameworks for the current
database. Building on the understanding gained from these
discussions, we have now contracted an IT company to
build the database, and work has progressed well on this.
The ultimate plan is to ready the database by the end of
August 2016, test its performance using our PPI group for
the next 1-2 months, and then prepare for launch in au-
tumn of 2016.
Results
The value of this database will primarily be assessed by
whether it proves useful and usable to researchers in fa-
cilitating recruitment into clinical trials on asthma and
whether patient privacy and data security are protected
in meeting this aim. A long-term ambition of electronic
health record systems is to facilitate patient access to
data. This is important to ensure record accuracy and
completeness, whilst being able to record the proven-
ance of data. Our long-term ambition for this database
is, therefore, to facilitate patient access to data, which is
a major UK policy; we plan to implement this compo-
nent in the database in due course.
Discussion
We have outlined the conceptual framework for creating a
digital population-based database for the recruitment of
participants who are eligible for, and consent to take part
in, future UK asthma clinical trials. To the best of our
knowledge, this is the first digital population-based recruit-
ment database specifically devoted for the conduct of clin-
ical trials on asthma. Although other analogous databases
exist in other parts of the world, as already highlighted in
Additional file 1, most of these, apart from the Scottish Dia-
betes Research Network, are generalist databases, i.e. they
do not have any particular disease focus. Although there is
no empirical evidence comparing the potentials of disease-
specific and generalist recruitment databases, our discus-
sions with asthma patient groups indicate that potential
participants appear open to databases that are tailored to
their specific disease conditions. An asthma recruitment
portal dedicated for the conduct of clinical trials on asthma
has immense future potential for improving health of
people affected with asthma. With a recruitment target of
300,000 participants in the first 5 years of setting up the
database through a range of recruitment avenues, we will
be in a position to undertake suitably powered clinical trials
to evaluate key questions on the management of asthma.
With the capacity to undertake cross-data linkages, the
database will consequently provide potentials for
addressing wide-ranging research questions on asthma, in-
cluding questions of intervention effects on different
asthma phenotypes, patient-reported asthma outcomes,
and an opportunity towards key targets of implementing
stratified healthcare in asthma.
Whilst it is possible that those with more labile and
poorly controlled asthma may more likely register to the
database, we think that such selective recruitment will
potentially impact on the external validity (or generalis-
ability) of the trials undertaken using the database, and
not on the internal validity. In developing this database,
our approach has been facilitated through extensive dis-
cussions with asthma patients, of varying degrees of
asthma severity, who have supported this work and
expressed an interest in participating for largely altruistic
reasons. Whilst we acknowledge that risk of selection
potentially remains, we believe that it is likely to be di-
minished over and above the current status quo.
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With the set-up of this database, we have the prospect
of substantially transforming the landscape of conducting
clinical trials on asthma in the UK. We hope that the time
taken for recruitment of participants into clinical trials will
substantially reduce, with the implication that clinical tri-
als on asthma can be undertaken in a more timely and
cost-efficient manner. We hope that such a resource as
the current database will contribute to attracting the inter-
est of international asthma investigators to the UK in
order to undertake cutting-edge clinical trials on asthma.
Finally, we believe that the database will also provide a
catalyst to help start cross-sectoral and cross-national col-
laborations, which will provide key outputs to influence
policy, practice, and research targets for the improved
management of asthma across all age groups.
Conclusion
Successful recruitment is a key determinant of the ultim-
ate success of any clinical trial. This database, the first of
its kind in the context of asthma, presents a novel ap-
proach to overcoming current recruitment barriers in
conducting clinical trials and will, therefore, facilitate
important clinical trials on asthma in the UK.
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